Abstract
The replication dynamics at common fragile site FRA6E has been evaluated by molecular combing and interphase fluorescent in situ hybridisation (FISH) in primary human lymphocytes cultured under normal or aphidicolin-induced stress conditions. FRA6E is one of the most frequently expressed common fragile sites of the human genome. It harbours several genes, PARK2 being regarded as the most relevant one. According to the results obtained from interphase FISH analysis, FRA6E can be considered a mid-late-replicating sequence characterised by heterogeneous replication timing. Molecular combing did not reveal specific replication parameters at the fragile site: fork rates were highly comparable to those detected at an early replicating locus (LMNB2) used as control and in very good agreement with the whole-genome data obtained in parallel. The same indication applied to the density of initiation zones, the inter-origin distances from adjacent ongoing forks, the frequencies of unidirectional forks, fork arrest events and asynchronous forks. Interestingly, PARK2 appeared embedded in an early/late replication transition zone, corresponding to intron 8 (162 kb) and to the fragility core of FRA6E. In cells exposed to aphidicolin, few forks progressing at a rather slow rate were observed, the majority of them being unidirectional, but again a specific response of the fragile site was not observed. In summary, at FRA6E the replication process is not impaired per se, but chromosome breakages occur preferentially at an early/late replication transition zone. Aphidicolin might increase the occurrence of breakage events at FRA6E by prolonging the time interval separating the replication of early and late replication domains. These results may be of general significance to address the problem of fragile site instability.
Similar content being viewed by others
References
Abdurashidova G, Deganuto M, Klima R, Riva S, Biamonti G, Giacca M, Falaschi A (2000) Start sites of bidirectional DNA synthesis at the human lamin B2 origin. Science 287:2023–2026
Arlt MF, Miller DE, Beer DG, Glover TW (2002) Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells. Genes Chromosom Cancer 33:82–92
Arlt MF, Durkin SG, Ragland RL, Glover TW (2006) Common fragile sites as targets for chromosome rearrangements. DNA Repair (Amst) 5:1126–1135. doi:10.1016/j.dnarep.2006.05.010
Becker NA, Thorland EC, Denison SR, Phillips LA, Smith DI (2002) Evidence that instability within the FRA3B region extends four megabases. Oncogene 21:8713–8722. doi:10.1038/sj.onc.1205950
Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ, Aldaz CM (2001) WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res 61:8068–8073
Berezney R, Dubey DD, Huberman JA (2000) Heterogeneity of eukaryotic replicons, replicon clusters, and replication foci. Chromosoma 108:471–484
Boggs BA, Chinault AC (1997) Analysis of DNA replication by fluorescence in situ hybridization. Methods 13:259–270. doi:10.1006/meth.1997.0525
Brewer BJ, Fangman WL (1993) Initiation at closely spaced replication origins in a yeast chromosome. Science 262:1728–1731
Callahan G, Denison SR, Phillips LA, Shridhar V, Smith DI (2003) Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene 22:590–601. doi:10.1038/sj.onc.1206171
Casper AM, Nghiem P, Arlt MF, Glover TW (2002) ATR regulates fragile site stability. Cell 111:779–789
Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R, McAdams H, Trapasso F, Drusco A, Shimizu M, Masciullo V, D’Andrilli G, Scambia G, Picchio MC, Alder H, Godwin AK, Croce CM (2003) Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25–q27. Proc Natl Acad Sci USA 100:5956–5961. doi:10.1073/pnas.0931262100
Conti C, Sacca B, Herrick J, Lalou C, Pommier Y, Bensimon A (2007) Replication fork velocities at adjacent replication origins are coordinately modified during DNA replication in human cells. Mol Biol Cell 18:3059–3067. doi:10.1091/mbc.E06-08-0689
Cordeiro-Stone M, Kaufman DG (1985) Kinetics of DNA replication in C3H 10T1/2 cells synchronized by aphidicolin. Biochemistry 24:4815–4822
Costantini M, Bernardi G (2008) Replication timing, chromosomal bands, and isochores. Proc Natl Acad Sci USA 105:3433–3437. doi:10.1073/pnas.0710587105
Costantini M, Clay O, Auletta F, Bernardi G (2006) An isochore map of human chromosomes. Genome Res 16:536–541. doi:10.1101/gr.4910606
Courbet S, Gay S, Arnoult N, Wronka G, Anglana M, Brison O, Debatisse M (2008) Replication fork movement sets chromatin loop size and origin choice in mammalian cells. Nature 455:557–560. doi:10.1038/nature07233
Debacker K, Kooy RF (2007) Fragile sites and human disease. Hum Mol Genet 16(2):R150-8. doi:10.1093/hmg/ddm136
Debatisse M, El Achkar E, Dutrillaux B (2006) Common fragile sites nested at the interfaces of early and late-replicating chromosome bands: cis acting components of the G2/M checkpoint? Cell Cycle 5:578–581
Denison SR, Callahan G, Becker NA, Phillips LA, Smith DI (2003a) Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer. Genes Chromosom Cancer 38:40–52. doi:10.1002/gcc.10236
Denison SR, Simper RK, Greenbaum IF (2003b) How common are common fragile sites in humans: interindividual variation in the distribution of aphidicolin-induced fragile sites. Cytogenet Genome Res 101:8–16. doi:10.1159/000073411
Denison SR, Wang F, Becker NA, Schule B, Kock N, Phillips LA, Klein C, Smith DI (2003c) Alterations in the common fragile site gene Parkin in ovarian and other cancers. Oncogene 22:8370–8378. doi:10.1038/sj.onc.1207072
Durkin SG, Glover TW (2007) Chromosome fragile sites. Annu Rev Genet 41:169–192. doi:10.1146/annurev.genet.41.042007.165900
El Achkar E, Gerbault-Seureau M, Muleris M, Dutrillaux B, Debatisse M (2005) Premature condensation induces breaks at the interface of early and late replicating chromosome bands bearing common fragile sites. Proc Natl Acad Sci USA 102:18069–18074. doi:10.1073/pnas.0506497102
Gemma A, Hagiwara K, Ke Y, Burke LM, Khan MA, Nagashima M, Bennett WP, Harris CC (1997) FHIT mutations in human primary gastric cancer. Cancer Res 57:1435–1437
Glover TW (2006) Common fragile sites. Cancer Lett 232:4–12. doi:10.1016/j.canlet.2005.08.032
Glover TW, Berger C, Coyle J, Echo B (1984) DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet 67:136–142
Hellman A, Rahat A, Scherer SW, Darvasi A, Tsui LC, Kerem B (2000) Replication delay along FRA7H, a common fragile site on human chromosome 7, leads to chromosomal instability. Mol Cell Biol 20:4420–4427
Herrick J, Bensimon A (2009) Introduction to molecular combing: genomics, DNA replication, and cancer. Meth Mol Biol 521:71–101
Krummel KA, Roberts LR, Kawakami M, Glover TW, Smith DI (2000) The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations. Genomics 69:37–46. doi:10.1006/geno.2000.6321
Laird C, Jaffe E, Karpen G, Lamb M, Nelson R (1987) Fragile sites in human chromosomes as regions of late-replicating DNA. Trends Genet 3:274–281
Le Beau MM, Drabkin H, Glover TW, Gemmill R, Rassool FV, McKeithan TW, Smith DI (1998a) An FHIT tumor suppressor gene? Genes Chromosom Cancer 21:281–289
Le Beau MM, Rassool FV, Neilly ME, Espinosa R 3rd, Glover TW, Smith DI, McKeithan TW (1998b) Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site induction. Hum Mol Genet 7:755–761
Lebofsky R, Heilig R, Sonnleitner M, Weissenbach J, Bensimon A (2006) DNA replication origin interference increases the spacing between initiation events in human cells. Mol Biol Cell 17:5337–5345. doi:10.1091/mbc.E06-04-0298
Letessier A, Garrido-Urbani S, Ginestier C, Fournier G, Esterni B, Monville F, Adelaide J, Geneix J, Xerri L, Dubreuil P, Viens P, Charafe-Jauffret E, Jacquemier J, Birnbaum D, Lopez M, Chaffanet M (2007) Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. Oncogene 26:298–307. doi:10.1038/sj.onc.1209772
Lukusa T, Fryns JP (2008) Human chromosome fragility. Biochim Biophys Acta 1779:3–16. doi:10.1016/j.bbagrm.2007.10.005
Mangelsdorf M, Ried K, Woollatt E, Dayan S, Eyre H, Finnis M, Hobson L, Nancarrow J, Venter D, Baker E, Richards RI (2000) Chromosomal fragile site FRA16D and DNA instability in cancer. Cancer Res 60:1683–1689
Marheineke K, Hyrien O (2001) Aphidicolin triggers a block to replication origin firing in Xenopus egg extracts. J Biol Chem 276:17092–17100. doi:10.1074/jbc.M100271200
McAvoy S, Zhu Y, Perez DS, James CD, Smith DI (2008) Disabled-1 is a large common fragile site gene, inactivated in multiple cancers. Genes Chromosom Cancer 47:165–174. doi:10.1002/gcc.20519
Michalet X, Ekong R, Fougerousse F, Rousseaux S, Schurra C, Hornigold N, van Slegtenhorst M, Wolfe J, Povey S, Beckmann JS, Bensimon A (1997) Dynamic molecular combing: stretching the whole human genome for high-resolution studies. Science 277:1518–1523
Palakodeti A, Han Y, Jiang Y, Le Beau MM (2004) The role of late/slow replication of the FRA16D in common fragile site induction. Genes Chromosom Cancer 39:71–76. doi:10.1002/gcc.10290
Palakodeti A, Lucas I, Jiang Y, Young DJ, Fernald AA, Karrison T, Le Beau MM (2010) Impaired replication dynamics at the FRA3B common fragile site. Hum Mol Genet 19:99–110. doi:10.1093/hmg/ddp470
Pelliccia F, Curatolo A, Limongi ZM, Bosco N, Rocchi A (2007) Transcriptional profiling of genes at the human common fragile site FRA1H in tumor-derived cell lines. Cancer Genet Cytogenet 178:144–150. doi:10.1016/j.cancergencyto.2007.07.004
Rhind N (2006) DNA replication timing: random thoughts about origin firing. Nat Cell Biol 8:1313–1316. doi:10.1038/ncb1206-1313
Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, Nancarrow JK, Woollatt E, Kremmidiotis G, Gardner A, Venter D, Baker E, Richards RI (2000) Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet 9:1651–1663
Rozier L, El-Achkar E, Apiou F, Debatisse M (2004) Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: possible association with an inherited disease and cancer. Oncogene 23:6872–6880. doi:10.1038/sj.onc.1207809
Schwartz M, Zlotorynski E, Kerem B (2006) The molecular basis of common and rare fragile sites. Cancer Lett 232:13–26. doi:10.1016/j.canlet.2005.07.039
Smith DI, McAvoy S, Zhu Y, Perez DS (2007) Large common fragile site genes and cancer. Semin Cancer Biol 17:31–41. doi:10.1016/j.semcancer.2006.10.003
Smith DI, Zhu Y, McAvoy S, Kuhn R (2006) Common fragile sites, extremely large genes, neural development and cancer. Cancer Lett 232:48–57. doi:10.1016/j.canlet.2005.06.049
Subramanian PS, Chinault AC (1997) Replication timing properties of the human HPRT locus on active, inactive and reactivated X chromosomes. Somat Cell Mol Genet 23:97–109
Tribioli C, Biamonti G, Giacca M, Colonna M, Riva S, Falaschi A (1987) Characterization of human DNA sequences synthesized at the onset of S-phase. Nucleic Acids Res 15:10211–10232
Wang L, Darling J, Zhang JS, Huang H, Liu W, Smith DI (1999) Allele-specific late replication and fragility of the most active common fragile site, FRA3B. Hum Mol Genet 8:431–437
Watanabe Y, Shibata K, Ikemura T, Maekawa M (2008) Replication timing of extremely large genes on human chromosomes 11q and 21q. Gene 421:74–80. doi:10.1016/j.gene.2008.06.016
Woodfine K, Beare DM, Ichimura K, Debernardi S, Mungall AJ, Fiegler H, Collins VP, Carter NP, Dunham I (2005) Replication timing of human chromosome 6. Cell Cycle 4:172–176
Yunis JJ, Soreng AL (1984) Constitutive fragile sites and cancer. Science 226:1199–1204
Acknowledgments
We are grateful to V. Bianchi (Department of Biology, University of Padova, Italy) and F. Pacchierotti (ENEA, CR Casaccia, Italy) for critical reading of the manuscript. This work was granted by the University of Padova (CPDA054385). A.R. has been the recipient of short-term travel grants from UICC (year 2004), EMBO (year 2005) and Ville de Paris (year 2006), which allowed her to learn the DNA molecular combing at the Institute Pasteur of Paris (France) in the former laboratory of A.B.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by E. Nigg
Electronic supplementary material
Below is the link to the electronic supplementary material.
Online resource 1
Schematic representation of FRA6E-PARK2 (A) and LAMIN B2 (B) genomic regions. Genes are represented by brownish-red bars, and those of interest are highlighted in purple. The genomic clones used as probes in FISH experiments on combed DNA are shown as blue bars. Probe RP11-21107, used only in interphase FISH experiments, is not visible, as it maps in 6q at 163.12-163.14 Mb. The position of flexibility peaks (detected as described in Online Resource 3) is indicated by a black line at the bottom of each panel. Clusters of flexibility are represented by green bars. Adapted from Ensembl genome browser. (GIF 70 kb)
Online resource 2
Flow cytometric analysis of APH treated lymphocytes. (GIF 90 kb)
Online resource 3
(DOC 21 kb)
Rights and permissions
About this article
Cite this article
Palumbo, E., Matricardi, L., Tosoni, E. et al. Replication dynamics at common fragile site FRA6E . Chromosoma 119, 575–587 (2010). https://doi.org/10.1007/s00412-010-0279-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00412-010-0279-4